1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow MVAp53 vaccine: new trials by email Literature Review of MVAp53 vaccine trials Research Report on MVAp53 vaccine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| P53MVA and Pembrolizumab in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Modified Vaccinia Virus Ankara Vaccine Expressing p53, Pembrolizumab - Recurrent Platinum-Resistant Fallopian Tube Carcinoma, Recurrent Platinum-Resistant Ovarian Carcinoma | Phase 2 | Active not recruiting | City of Hope Medical Center | 29 | 2019-05-01 | 2026-11-03 |
City of Hope Medical Center (1)
United States (1)
Thanh Dellinger (1)
P30CA033572 (1)